Physician profile
Denton Watumull
NPI 1225073216
$5,623.17
in general payments reported to CMS, 2019-2025
17 companies · $420 in 2025
The $420 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,794 · 2020: $267 · 2021: $737 · 2022: $673 · 2023: $355 · 2024: $377 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,152.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,844.05 | 2019-2022 | |
| Abbvie INC. | $768.18 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Davol INC. | $440.12 | 2019-2022 | |
| Sientra, INC. | $431.06 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $220.92 | 2021 | |
| Mentor Worldwide LLC | $163.40 | 2019-2021 | |
| Stryker Corporation | $142.38 | 2019 | |
| Medical Device Business Services, INC. | $124.32 | 2025 | Dermabond |
| Pacira Pharmaceuticals Incorporated | $121.66 | 2019-2022 | |
| Tela Bio, INC. | $84.98 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Axogen | $83.45 | 2025 | |
| Apyx Medical Corporation | $53.35 | 2019-2020 | |
| Musculoskeletal Transplant Foundation INC. | $53.34 | 2021-2023 | |
| Medtronic, INC. | $32.57 | 2022 | |
| Polynovo North America LLC | $25.10 | 2025 | Novosorb Btm |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $20.32 | 2023 | Durasorb Monofilament Mesh |
| Cook Medical LLC | $13.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denton Watumull listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.